Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Bioorganic & Medicinal Chemistry
|
September 9, 2022
Design, Synthesis, and Biological Evaluation of New 1H-Imidazole-2-Carboxylic Acid Derivatives as Metallo-β-Lactamase Inhibitors
Rong Li, Huilin Su, Wei Chen, et al.
European Journal of Medicinal Chemistry
|
November 12, 2021
Structure-guided optimization of 1H-imidazole-2-carboxylic acid derivatives affording potent VIM-Type metallo-β-lactamase inhibitors
Yu-Hang Yan, Wenfang Li, Wei Chen, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 21, 2021
Discovery of 3-aryl substituted benzoxaboroles as broad-spectrum inhibitors of serine- and metallo-β-lactamases
Yu-Hang Yan, Zhao-Feng Li, Xiang-Li Ning, et al.
European Journal of Medicinal Chemistry
|
March 13, 2020
Sensitive fluorogenic substrates for sirtuin deacylase inhibitor discovery
Ling-Ling Yang, Hua-Li Wang, Yu-Hang Yan, et al.
European Journal of Medicinal Chemistry
|
August 30, 2021
Discovery of new human Sirtuin 5 inhibitors by mimicking glutaryl-lysine substrates
Fan Yang, Huilin Su, Ji Deng, et al.
European Journal of Medicinal Chemistry
|
May 20, 2023
Metal binding pharmacophore click-derived discovery of new broad-spectrum metallo-β-lactamase inhibitors
Yu-Hang Yan, Hao-Sheng Ding, Kai-Rong Zhu, et al.
Bioorganic Chemistry
|
March 30, 2023
New ε-N-thioglutaryl-lysine derivatives as SIRT5 inhibitors: Chemical synthesis, kinetic and crystallographic studies
Ji Deng, Ze-Min Liu, Kai-Rong Zhu, et al.
Chemical Communications (Cambridge, England)
|
July 14, 2021
Design and enantioselective synthesis of 3-(α-acrylic acid) benzoxaboroles to combat carbapenemase resistance
You-Cai Xiao, Xiao-Pan Chen, Ji Deng, et al.
Journal of Medicinal Chemistry
|
March 7, 2025
Discovery of New Azaindole Metallo-Deubiquitinase CSN5 Inhibitors
Pengcheng Lei, Yu-Hang Yan, Yingying Jiang, et al.
Journal of Medicinal Chemistry
|
February 18, 2026
A Novel CSN5 Inhibitor Drives Tumor-Intrinsic PD-L1 Degradation and Exerts Direct Antitumor Efficacy in Triple-Negative Breast Cancer
Yanjun Wang, Hui Lei, Wenyi Liu, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Bioorganic & Medicinal Chemistry
|
September 9, 2022
Design, Synthesis, and Biological Evaluation of New 1H-Imidazole-2-Carboxylic Acid Derivatives as Metallo-β-Lactamase Inhibitors
Rong Li, Huilin Su, Wei Chen, et al.
European Journal of Medicinal Chemistry
|
November 12, 2021
Structure-guided optimization of 1H-imidazole-2-carboxylic acid derivatives affording potent VIM-Type metallo-β-lactamase inhibitors
Yu-Hang Yan, Wenfang Li, Wei Chen, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 21, 2021
Discovery of 3-aryl substituted benzoxaboroles as broad-spectrum inhibitors of serine- and metallo-β-lactamases
Yu-Hang Yan, Zhao-Feng Li, Xiang-Li Ning, et al.
European Journal of Medicinal Chemistry
|
March 13, 2020
Sensitive fluorogenic substrates for sirtuin deacylase inhibitor discovery
Ling-Ling Yang, Hua-Li Wang, Yu-Hang Yan, et al.
European Journal of Medicinal Chemistry
|
August 30, 2021
Discovery of new human Sirtuin 5 inhibitors by mimicking glutaryl-lysine substrates
Fan Yang, Huilin Su, Ji Deng, et al.
European Journal of Medicinal Chemistry
|
May 20, 2023
Metal binding pharmacophore click-derived discovery of new broad-spectrum metallo-β-lactamase inhibitors
Yu-Hang Yan, Hao-Sheng Ding, Kai-Rong Zhu, et al.
Bioorganic Chemistry
|
March 30, 2023
New ε-N-thioglutaryl-lysine derivatives as SIRT5 inhibitors: Chemical synthesis, kinetic and crystallographic studies
Ji Deng, Ze-Min Liu, Kai-Rong Zhu, et al.
Chemical Communications (Cambridge, England)
|
July 14, 2021
Design and enantioselective synthesis of 3-(α-acrylic acid) benzoxaboroles to combat carbapenemase resistance
You-Cai Xiao, Xiao-Pan Chen, Ji Deng, et al.
Journal of Medicinal Chemistry
|
March 7, 2025
Discovery of New Azaindole Metallo-Deubiquitinase CSN5 Inhibitors
Pengcheng Lei, Yu-Hang Yan, Yingying Jiang, et al.
Journal of Medicinal Chemistry
|
February 18, 2026
A Novel CSN5 Inhibitor Drives Tumor-Intrinsic PD-L1 Degradation and Exerts Direct Antitumor Efficacy in Triple-Negative Breast Cancer
Yanjun Wang, Hui Lei, Wenyi Liu, et al.
Page
of 3